Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.


IndexRUT P/E- EPS (ttm)-0.55 Insider Own38.42% Shs Outstand478.67M Perf Week0.23%
Market Cap1.08B Forward P/E- EPS next Y-0.67 Insider Trans0.00% Shs Float300.12M Perf Month-4.11%
Income-262.78M PEG- EPS next Q-0.16 Inst Own40.72% Short Float / Ratio4.42% / 2.89 Perf Quarter14.18%
Sales0.00M P/S- EPS this Y-88.89% Inst Trans20.57% Short Interest13.27M Perf Half Y13.01%
Book/sh2.58 P/B0.86 EPS next Y1.47% ROA-18.00% Target Price- Perf Year-55.25%
Cash/sh2.59 P/C0.86 EPS next 5Y- ROE-19.30% 52W Range1.58 - 5.70 Perf YTD-9.96%
Dividend- P/FCF- EPS past 5Y- ROI-21.05% 52W High-61.17% Beta0.49
Dividend %- Quick Ratio22.60 Sales past 5Y0.00% Gross Margin- 52W Low40.19% ATR0.06
Employees362 Current Ratio22.60 Sales Q/Q- Oper. Margin0.00% RSI (14)46.48 Volatility2.17% 2.60%
OptionableYes Debt/Eq0.00 EPS Q/Q13.30% Profit Margin- Rel Volume0.77 Prev Close2.21
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume4.60M Price2.21
Recom- SMA20-1.73% SMA501.33% SMA2006.48% Volume885,611 Change0.23%
Date Action Analyst Rating Change Price Target Change
Nov-14-22Downgrade JP Morgan Neutral → Underweight
Nov-11-22Downgrade Jefferies Buy → Hold $5.60 → $3.20
Nov-11-22Downgrade Goldman Buy → Neutral $8 → $5
Aug-16-22Initiated JP Morgan Neutral $5.50
Jun-13-22Initiated Goldman Buy $8
Apr-22-22Initiated Cowen Outperform
Mar-18-22Initiated Jefferies Buy $5.60
Aug-01-23 07:00AM
May-08-23 04:01PM
Apr-27-23 08:00AM
Feb-23-23 07:00AM
Jan-03-23 08:00AM
08:00AM Loading…
Dec-19-22 08:00AM
Dec-02-22 08:00AM
Nov-10-22 07:00AM
Nov-07-22 08:00AM
Oct-28-22 08:00AM
Aug-11-22 07:00AM
Aug-07-22 04:10AM
Jul-28-22 08:00AM
Jul-03-22 08:22AM
Jun-14-22 07:00AM
08:00AM Loading…
May-31-22 08:00AM
May-26-22 05:00PM
May-13-22 07:00AM
Apr-29-22 08:00AM
Apr-27-22 10:30AM
Mar-24-22 11:39AM
Mar-23-22 07:00AM
Mar-09-22 08:00AM
Mar-02-22 08:00AM
Jan-18-22 07:00PM
Jan-10-22 07:30AM
Jan-07-22 08:00AM
Jan-03-22 08:00AM
Dec-24-21 06:35AM
EQRx, Inc. is a pharmaceutical company, which engages in developing and delivering innovative medicines to patients having chronic conditions. The company was founded by Alexis A. Borisy, Sandra J. Horning, Robert M. Forrester, Peter Bach, and Melanie I. Nallicheri on August 26, 2019 and is headquartered in Cambridge, MA.